INTRODUCTION
Colorectal cancer is the second most common cause of cancer-related mortality in the U.S., with an expected 50,000 deaths for 2008 [1] . At presentation, approximately 20% of patients have stage IV disease [2] . In these cases, primary tumor resection (PTR) is required for complications such as bowel obstruction, perforation, and bleeding, but remains controversial in patients with mild or no symptoms [3, 4] . A number of authors have reported low rates of primary tumor-related complications when these patients are treated medically with their primary tumor in situ [5] , and this practice has become more common in recent years [6] .
However, bowel obstruction remains the most common primary tumor-related complication during medical therapy for stage IV colorectal cancer [2, 5, 7] . Ideally, patients who will develop bowel obstruction should be identified when their tumor is diagnosed and offered prophylactic colonic diversion or PTR. Colonoscopy is widely used for the diagnosis of colorectal cancer and provides information about tumor site, morphology, and degree of luminal obstruction. We hypothesized that colonoscopic findings such as tumor site, inability to advance the colonoscope beyond the primary tumor, and the presence of circumferential, near-obstructing lesions at the time of diagnosis predict the need for operative intervention for symptomatic bowel obstruction.
The aims of this study were to evaluate the utility of colonoscopic findings and tumor site as indications for prophylactic PTR or colonic diversion to prevent bowel obstruction in patients with stage IV colorectal cancer.
MATERIALS AND METHODS
The prospectively maintained medical oncology and hepatectomy databases of the University of Wisconsin Hospital for the years 1993-2007 were retrospectively reviewed after approval from the institutional review board. All patients presenting with pathologically confirmed stage IV colorectal adenocarcinoma without previous surgical or medical treatment were included. Exclusion criteria were incomplete colonoscopy reports, operative reports and lack of follow-up data. Colonoscopy reports were reviewed to identify the primary tumor site, presence of circumferential or near-obstructing lesions, and inability to advance the colonoscope beyond the tumor as a result of luminal obstruction. Patients with at least one of these findings were defined as meeting high-risk colonoscopic criteria for bowel obstruction during medical treatment. Right-sided lesions were defined as proximal to the midtransverse colon, whereas all other tumors were classified as left-sided lesions. Additional data collected were age, gender, duration of medical treatment until death or delayed PTR, primary tumor-related complications as well as indications for and timing and type of surgical treatment. Early PTR was defined as PTR before initiation of medical treatment, whereas delayed PTR was defined as PTR after initiation of medical treatment. Student's t-test and Fisher's exact test were used to compare continuous and noncontinuous variables, respectively, with p Յ .05 representing statistical significance. Log-rank and Kruskal-Wallis tests were used to compare trends across groups. Results are presented as mean Ϯ standard deviation.
RESULTS
Fifty-six patients presented to our center in 1993-2007 with stage IV colorectal cancer and no previous PTR or medical treatment. Seven patients were excluded as a result of previous diverting colostomy or absent colonoscopy reports, yielding 49 patients for analysis (Fig. 1) . No patient underwent colonic diversion or stenting during the course of his or her disease and there were no cases of emergency surgery for bowel obstruction.
Twenty of the 49 patients (40%) had high-risk colonoscopic findings, such as circumferential, near-obstructing lesions and inability to advance the colonoscope beyond the primary tumor at presentation (Table 1 ). There was a significantly lower proportion of rectal tumors in these patients than in patients with no such findings (25% versus 62%; p ϭ .02). There were no significant differences in age, sex, or computed tomography findings between the two groups ( Table 1) .
We consider symptoms of bowel obstruction a clear indication for PTR or colonic diversion. We found that 40% of patients in the high-risk group, compared with only 3% of patients in the low-risk group, had symptoms of bowel obstruction at presentation necessitating early PTR (p ϭ .002) ( Table 2 ). An additional eight patients, including two in the high-risk group, underwent early PTR for rectal bleeding ( Table 2 ). Twenty-four other patients underwent delayed PTR. Indications for and timing of PTR are shown in Table 2 and did not differ significantly between patients with and without high-risk colonoscopic criteria. Abbreviations: PTR, primary tumor resection; SD, standard deviation.
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Survival and time to delayed PTR were determined in 32 patients who did not undergo early PTR and received medical therapy with their primary tumor in situ. There were no significant differences in either parameter between 10 patients with and 22 patients without high-risk colonoscopic findings ( Fig. 2A, 2B) .
We did not find an association between tumor site and requirement for or timing of PTR (Table 3) . Finally, even patients with both criteria present (i.e., concurrent leftsided tumors and high-risk colonoscopic findings) had no significant differences in requirement for or timing of PTR compared with patients with right-sided tumors and lowrisk colonoscopic findings (Table 3) .
DISCUSSION
In this study, we examined the utility of tumor site and colonoscopic findings in predicting bowel obstruction in patients with stage IV colorectal cancer undergoing medical treatment. We show that patients with near-obstructing lesions are more likely to present with symptoms of bowel obstruction leading to early PTR. However, patients with high-risk primary tumors without symptoms are no more likely to require resection as a result of developing obstruction than are patients who have low-risk primary tumors.
PTR in asymptomatic stage IV colorectal cancer patients was advocated in the 1960s to prevent complications related to the primary tumor such as obstruction, perforation, and bleeding [8 -10] . However, the perioperative morbidity and mortality for PTR in stage IV colorectal cancer can reach 47% and 4.6%, respectively [2-3, 5, 11, 12] . Moreover, bowel obstruction after PTR can reach 13.4%, a figure similar to the 13.9% incidence of bowel obstruction in 314 patients not undergoing PTR reported in a recent meta-analysis [7, 12] . In recent years, a number of studies have demonstrated that medical treatment without prior PTR is safe and does not affect survival when corrected for performance status, presence of peritoneal and omental metastases, number of distant sites involved, and volume of hepatic replacement by metastases [5, 12, 13] . A recent review of the Surveillance, Epidemiology, and End Results (SEER) database revealed that one third of patients with stage IV colorectal cancer do not undergo PTR during the Confidential Pre-Print PDF This material is protected by U.S. Copyright law. Unauthorized reproduction is prohibited.
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Colonoscopic Findings Do Not Predict Bowel Obstruction course of their disease [6] . A large number of patients initially receive medical therapy and are treated with delayed PTR with or without metastasectomy depending on response to treatment [14] . In these patients, bowel obstruction is the most common primary tumor-related complication, with an incidence of 3%-29% during the course of their disease (Table 4) [2, 5, 7, 15, 16] . In order to prevent the symptoms and complications of bowel obstruction, patients likely to obstruct should be identified at diagnosis and offered prophylactic colonic diversion or PTR. Although severe obstructive symptoms at presentation are an indication for surgical intervention, asymptomatic patients can develop obstruction during medical therapy if their tumor is left in situ. In a recent study by Ruo et al. [2] , 30 of 103 patients undergoing medical therapy for stage IV colorectal cancer with their primary tumor in situ required operative intervention for bowel obstruction. Only two of those patients had obstructive symptoms at presentation. Hence, better criteria to identify patients at risk for bowel obstruction are needed.
In this study, we defined lesions described as "circumferential" and/or "near-obstructing" and/or preventing proximal advancement of the colonoscope as high risk for subsequent bowel obstruction. These characteristics were found in 40% of patients presenting with stage IV colorectal cancer. To our knowledge, previous studies have not described the prevalence of obstructing lesions at the time of colorectal cancer diagnosis. In another study, one third of patients requiring PTR or colonic diversion for bowel obstruction during medical therapy for stage IV colorectal cancer had "partial obstruction on initial endoscopic evaluation," although the colonoscopic characteristics of these lesions were not further specified [2] . Colonoscopy cannot objectively measure the degree of luminal obstruction caused by a tumor and findings are difficult to standardize among colonoscopists. However, descriptions of colonoscopic findings are often used by surgeons and medical oncologists to estimate the severity of luminal obstruction and can influence surgical management.
We found a statistically significant association of highrisk colonoscopic findings and symptoms of bowel obstruction requiring PTR at the time of diagnosis. Despite this finding, 10 of 20 patients with and 22 of 29 patients without high-risk colonoscopic findings did not undergo early PTR and received medical therapy with or without delayed PTR. Others have found that almost all stage IV colorectal patients who develop bowel obstruction during medical treatment do so within 6 months of diagnosis [2, 6, 17, 18] . In our study, the mean duration of medical treatment was approximately 6 months, with no patients requiring any type of intervention for bowel obstruction.
Similar to the colonoscopic findings, lesion site did not predict symptomatic bowel obstruction during medical treatment for stage IV colorectal cancer. Interestingly, symptomatic bowel obstruction requiring early PTR was more likely in patients with right-sided lesions, although this difference did not reach statistical significance. In some large series that included colorectal cancer patients of all stages, patients with left-sided lesions were more likely to present with bowel obstruction, although other studies found no difference. Carraro et al. [19] reported that, in 336 patients with colorectal cancer, 35% of patients with leftsided lesions and 18% of patients with right-sided lesions presented with bowel obstruction (p ϭ .002). In a series of 12,113 colorectal cancer patients with known tumor sites that can be compared with our study, no difference in incidence of bowel obstruction between patients with left-and right-sided tumors (9% versus 8%, respectively; p ϭ .35) was shown [20] . In a meta-analysis of 314 patients with stage IV colorectal cancer undergoing chemotherapy with their primary tumor in situ, 21% and 12% of patients with left-and right-sided lesions, respectively, developed obstruction, a difference that was statistically significant [12] .
CONCLUSION
The presence of left-sided tumors and high-risk colonoscopic findings is not associated with a higher risk for bowel obstruction in stage IV colorectal cancer patients undergoing medical treatment with their primary tumor in situ. The decision to perform PTR or colonic diversion in these patients at the time of diagnosis should depend on the presence of symptoms related to their primary tumor and not colonoscopic findings or tumor site.
